Songling Xuemaikang Capsule (松龄血脉康胶囊) for primary hypertension: a systematic review of randomized controlled trials

X Yang, X Xiong, G Yang, H Wang, J Wang - Chinese journal of integrative …, 2015 - Springer
Objective To evaluate the effectiveness and safety of Songling Xuemaikang Capsule
(松龄血脉康胶囊, SXC) for the treatment of primary hypertension. Methods An extensive …

[HTML][HTML] Efficacy and safety of songling xuemaikang capsule for essential hypertension: A systematic review and meta-analysis of randomized controlled trials

T Meng, P Wang, X Xie, T Li, L Kong, Y Xu, K Cao… - Phytomedicine, 2022 - Elsevier
Background Hypertension is one of the most significant public health challenges worldwide.
An increasing number of patients prefer to incorporate traditional Chinese medicine into …

A propensity score matched comparison of blood pressure lowering in essential hypertension patients treated with antihypertensive Chinese herbal Medicine …

X Lai, Z Fang, Z Dong, S Wu, X Zhou… - Clinical and Experimental …, 2023 - Taylor & Francis
Background Randomized controlled trials have demonstrated that Songling Xuemaikang
capsule (SXC) is effective in blood pressure (BP) lowering for essential hypertension …

Songling Xuemaikang capsules for patients with low-to-medium risk hypertension: study protocol for a randomized controlled trial

Y Jiang, H Guo, Y Liu, X Wang, J Liang, R Xi, R Bai… - Trials, 2019 - Springer
Background Hypertension is a major risk factor for cardio-cerebrovascular disease. Songling
Xuemaikang capsules (SXC), a formulation of Chinese herbal patent medicine, has been …

Efficacy and safety of Chinese herbal medicine compared with losartan for mild essential hypertension: A randomized, multicenter, double-blind, noninferiority trial

X Lai, Z Dong, S Wu, X Zhou, G Zhang… - … Quality and Outcomes, 2022 - Am Heart Assoc
Background: Hypertension is one of the most challenging public health problems worldwide.
Previous studies suggested that the Songling Xuemaikang capsule (SXC)—a Chinese …

Effects of Songling Xuemaikang Capsule on ambulatory blood pressure in treatment of essential hypertension: a single-blind randomized controlled trial

L Fu, ZX Mao, J Wang, J Zhang, TR Zheng… - Zhong xi yi jie he xue …, 2009 - europepmc.org
Objective To explore the effects of Western medicine including Ca (2+) channel antagonist
and angiotensin-receptor antagonist combined with Songling Xuemaikang Capsule (SXC) …

Is Yangxue Qingnao Granule combined with antihypertensive drugs, a new integrative medicine therapy, more effective than antihypertensive therapy alone in treating …

J Wang, X Yang, B Feng, W Qian… - Evidence‐Based …, 2013 - Wiley Online Library
Background. Yangxue Qingnao granule (YQG) combined with antihypertensive drugs, a
new integrative medicine therapy, has been widely used for essential hypertension (EH) in …

Chinese patent medicine tongxinluo capsule for hypertension: a systematic review of randomised controlled trials

J Wang, X Xiong, W Liu - Evidence‐Based Complementary …, 2014 - Wiley Online Library
Background. This study was intended to evaluate the efficacy and safety of Tongxinluo
capsule for hypertension. Search Strategy. We searched the Cochrane Central Register of …

[HTML][HTML] 松龄血脉康胶囊对原发性高血压患者动态血压相关指标的影响: 随机单盲对照试验

付莉, 毛振兴, 王静, 张静, 郑太蓉… - Journal of Integrative …, 2009 - jcimjournal.com
Objective To explore the effects of Western medicine including Ca 2+ channel antagonist
and angiotensin-receptor antagonist combined with Songling Xuemaikang Capsule (SXC) …

[HTML][HTML] Efficacy and safety of Shugan Jieyu capsule in the treatment of essential hypertension with insomnia, anxiety or depression: a protocol for systematic review …

M Fan, D Guo, Y Tian, Y Liu, J Zhao - Medicine, 2021 - journals.lww.com
Background: Shugan Jieyu capsule can reduce blood pressure and improve its concomitant
symptoms. However, it is not widely used in clinic because of its incomplete understanding …